Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2003
11/06/2003CA2482455A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003CA2481324A1 [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480092A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/05/2003EP1359215A1 Soya cell strains with high isoflavone content
11/05/2003EP1359159A2 Analogues of GLP-1
11/05/2003EP1358895A1 Tissue equivalant for transplantation and process for producing the same
11/05/2003EP1358881A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
11/05/2003EP1358878A1 Remedies/preventives for inflammatory diseases
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358206A2 Peptide-based compounds
11/05/2003EP1358188A2 Antagonists of mcp-1 function and methods of use thereof
11/05/2003EP1358187A2 Naphthyridine derivatives
11/05/2003EP1358186A1 Laulimalide derivatives
11/05/2003EP1358185A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
11/05/2003EP1358183A2 Cysteine protease inhibitors
11/05/2003EP1358182A1 Diazocine derivatives and their use as tryptase inhibitors
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358155A1 Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as mmp inhibitors
11/05/2003EP1357937A2 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology
11/05/2003EP1357925A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003EP1357903A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO b]THIOPHENE AND SALTS THEREOF
11/05/2003EP1357881A2 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
11/05/2003EP1178960B1 Vitamin d analogues and their pharmaceutical use
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1082298B1 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454210A 嘧啶衍生物 Pyrimidine derivatives
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453010A Liniment for treating rheumarthritis and similar diseases and its prepn
11/05/2003CN1452995A Externally applied paste for treating fracture and injured tendons
11/05/2003CN1452989A Medicated wine for treating rheumatism and rheumatoid disease
11/05/2003CN1452983A Delayed-releasing compound diclofenac sodium prepn
11/05/2003CN1126737C Novel pyrrole compound, its preparation and pharmaceutical composition containing the same
11/05/2003CN1126556C Lumbago plaster
11/04/2003US6642266 EP4 receptor selective agonists in the treatment of osteoporosis
11/04/2003US6642255 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642241 Alkylamino- substituted dihydropyrimido-(4,5-d)pyrimidinone derivatives, inhibitors of p38,
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642225 Diazacycloalkanedione derivatives
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
11/04/2003US6642216 Osteoporosis, periodontal diseases
11/04/2003US6642010 Identifying, monitoring, and treating women for breast precancer or cancer
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641806 Inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, nonbovine proteoglycan such as
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
11/04/2003CA2257322C Thiazole derivatives
11/04/2003CA2094773C 2,4-dioxoimidazolidine derivatives
11/03/2003CA2427574A1 Plant bioreactor
10/2003
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089430A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003WO2003089427A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003089010A1 Glycodendrimers having biological activity
10/30/2003WO2003088977A1 (20S)-1α-HYDROXY-2α-METHYL AND 2β-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
10/30/2003WO2003088976A1 Method for treating and preventing hyperparathyroidism
10/30/2003WO2003088974A1 Pharmaceutical composition
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088905A2 Compositions and minimally invasive methods for treating incomplete tissue repair
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003048148A3 Statin-like compounds
10/30/2003WO2003045404A3 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003020309A3 Compound
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003004661A3 Adenovital vectors with cell type specificity for mesenchymal cells
10/30/2003WO2002098391A3 Process for preparing granular compositions
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002087563A3 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002050243A3 The use of ecm degrading enzymes for the improvement of cell transplantation
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003WO2001051054A3 Use of cyclopentenone derivatives for bone and periodontal regeneration
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
1 ... 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 ... 820